Comparison

Moracin O European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Format Powder
Amount 5mg
Item no. TMO-TN1951-5mg
CASRN 123702-97-6
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Moracin O shows significant neuroprotective, and analgesic activities, it also has a strong protective influence against doxorubicin-induced cardiomyopathy in H9c2 cells with the EC50 value of 4.5 ± 1.3 μM. Moracin O exhibits potent in vitro inhibitory activity against hypoxia-inducible factor (HIF-1), which is a key mediator during adaptation of cancer cells to tumour hypoxia.
Shipping
cool pack
Storage
-20°
Molecular Weight
326, 34
Pathway
Chromatin/Epigenetic|||Angiogenesis
Target
HIF

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Delivery expected until 5/30/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?